P. Uike, P. Hiwarkar, V. Malkar, and K. Aswalle, “Profile of multi drug resistant (MDR) and rifampicin resistant TB patients treated under category IV of RNTCP”, Int J Basic Clin Pharmacol, vol. 6, no. 4, pp. 784–787, Mar. 2017.